IPCA Labs - Strength in the Pharma sector
One of the few stocks which has had USFDA issues but eventually took it into its stride..
They focused more on the domestic market and now have a strong local franchise.
Long above 960 with a stoploss below 930.
The stock could breakout and move vertically.
They focused more on the domestic market and now have a strong local franchise.
Long above 960 with a stoploss below 930.
The stock could breakout and move vertically.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。